Connect with us

INDUSTRIAL HEMP

Axim Biotechnologies Inc (OTCMKTS:AXIM) Targets Cannabinoid-based Ophthalmic Offerings

Published

on

Axim Biotechnologies Inc

SECFilings.com published an article covering the ophthalmology segment and Axim Biotechnologies Inc (OTCMKTS:AXIM) cannabinoid-based therapies. International ophthalmology revenue is expected to grow at a compound annual growth rate of 9.48% to $26 billion by 2022 from $13.7 billion in 2015, according to Research and Markets. Irrespective of medical advances, most ophthalmic problems cannot be cured and treatment is intended at managing the disease indication to lower the severity of indications and reduce the advancement of visual field loss over time.

The details

AXIM Biotechnologies considers that cannabinoids could play a vital role in managing ophthalmology indications and probably even reversing some ailments. With two plans in its clinical pipeline, the firm is targeting dry eye and glaucoma, two of the most widespread ophthalmological problems. The concept that cannabinoids can be useful in treating glaucoma goes back to the 1970s.

Trials performed then demonstrated that smoking marijuana lowered IOP in people with glaucoma, however the effects only remained for just three or four hours. In addition, smoking pot resulted in a drop in blood pressure that may result in a harmful decline in blood flow to the already-weak optic nerve.

In 2000, researchers advanced a non-psychotropic synthetic cannabinoid named as HU-211, and identified that a single dose lowered IOP by 5.3 mmHg in rabbits over a 6-hour period. Since the Hemp was given locally, there was no systemic decline in blood pressure that would have led the optic nerve at risk. This data demonstrated that non-whole-plant or synthetic cannabinoids could play a vital role in ophthalmology.

Researchers have considered these findings and other innovations and used them to grow into other segments of ophthalmology, ranging from inflammatory ailments of the eye to the problem of dry eye. Google Scholar lists around 600 papers issued this year alone covering the words “ophthalmology” and “cannabinoid”, which suggests a grown interest in the segment. Axim Biotechnologies has joined these positions with at least two clinical plans in process.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of journaltranscript.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure

BRANDS

DETAILS

SCORE

PRODUCT SITES

  • Certified Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49

9.8

30% OFF Today! “30 0FF”

  • All Natural
  • Made In U.S.A
  • Lab Tested
  • Price From $69

9.7

  • All Natural
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99

9.6

  • All Natural
  • Made In U.S.A
  • Oral Mist
  • Price From $39

9.5

BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49
SCORE

9.8

PRODUCT SITE
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Lab Tested
  • Price From $69
SCORE

9.7

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99
SCORE

9.6

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Oral Mist
  • Price From $39
SCORE

9.5

PRODUCT SITE VIEW PRODUCTS
Advertisement

Title

Uncategorized6 hours ago

Top 15 Essential Oils + Health Benefits

Top 15 Essential Oils + Health Benefits Each and every essential oil contains compounds with unique healing and therapeutic benefits....

Uncategorized6 hours ago

Using Hemp Oil in Cooking

Hemp oil has many advocates. The oil from hemp seeds is rich in omega-3 and omega-6 essential fatty acids. This makes...

Uncategorized4 days ago

Best Oil Producers of 2018

Millionaires are being made by the moment in the medical marijuana industry. Venture capital firms, private equity firms, and even...

MyDx Inc MyDx Inc
Health2 weeks ago

MyDx Inc. (OTCMKTS:MYDX) Initiates Clinical Trial of Cannabis Formula for The Treatment of Chronic Low Back Pain

San Diego, CA based MyDx Inc. (OTCMKTS:MYDX) has announced the controlled trial of the cannabis formula for the treatment of...

Business2 weeks ago

Fastfunds Financial Corporation (OTCMKTS:FFFC) Is All Set to Launch Affinity Connextions Program Targeting MMJ Industry

Fastfunds Financial Corporation (OTCMKTS:FFFC) has announced the completion of all necessary formalities to introduce an Affinity Connextions Program through a...

Innovative Industrial Properties Inc Innovative Industrial Properties Inc
Business2 weeks ago

Innovative Industrial Properties, Inc (NYSE:IIPR) Unveils Exercise Of Underwriter’s Option To Purchase Common Stock Shares

Innovative Industrial Properties, Inc (NYSE:IIPR) announced recently that it has obtained the exercise of the underwriter’s option to buy additional...

Business2 weeks ago

Next Generation Management Corporation (OTCMKTS:NGMC) Updates On New Medical Marijuana System in Oregon

Nextgen Holdings, a subsidiary of the Next Generation Management Corporation (OTCMKTS:NGMC) recently updated its stockholders with the ongoing Medical Marijuana...

INDUSTRIAL HEMP2 weeks ago

Weed Inc’s (OTCMKTS:BUDZ) Performance Is Getting Higher

Weed Inc (OTCMKTS:BUDZ) has for a long time been enjoying the momentous highs for the past few months. The company’s...

INDUSTRIAL HEMP2 weeks ago

Namaste Technologies Inc (OTCMKTS:NXTTF) Signs A Share Purchase Agreement With Cannbit Ltd

Namaste Technologies Inc (OTCMKTS:NXTTF) announced recently that it signed a non-binding Letter of Intent (LOI) with Cannabit Limited where the...

INDUSTRIAL HEMP2 weeks ago

MariMed Inc. (OTCMKTS:MRMD) Plans To Expand Its Cannabis Business

MeriMed Inc. (OTCMKTS:MRMD) announced its grand plans to expand business into the emerging cannabis industry. Furthermore, the company intends to...

Advertisement
Advertisement
Advertisement